Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Chronic Graft-Versus-Host Disease in Long-Term Survivors of Childhood Leukemia

Blood (2023) 142 (Supplement 1): 3762.

https://doi.org/10.1182/blood-2023-178121

Published: 2023

Journal Articles

Conditioning Intensity in Patients Aged > 50 Years Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrom: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT

Blood (2023) 142 (Supplement 1): 472.

https://doi.org/10.1182/blood-2023-172796

Published: 2023

Journal Articles

High Body Mass Index Is Associated with Favorable Outcome in Younger Patients Receiving CD19 CAR T-Cell Therapy for B-Cell Lymphoma: A Retrospective Study from the EBMT Transplant Complications Working Party

Blood (2023) 142 (Supplement 1): 4867.

https://doi.org/10.1182/blood-2023-187393

Published: 2023

Journal Articles

Interest of Cytoreductive Therapy before Allogenic Hematopoietic Stem Cell Transplantation in Childhood Myelodysplastic Syndromes: A Retrospective Study on Behalf of the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Baptiste Le Calvez, Maxime Jullien, Jean-Hugues Dalle, Cécile Renard, Charlotte Jubert, Arthur Sterin, Catherine Paillard, Anne Huynh, Sarah Guenounou, Benedicte Bruno, Virginie Gandemer, Nimrod Buchbinder, Pauline Simon, Cecile Pochon, Anne Sirvent, Dominique Plantaz, Justyna Kanold, Fanny Rialland Battisti, Audrey Grain

Blood (2023) 142 (Supplement 1): 1833.

https://doi.org/10.1182/blood-2023-181821

Published: 2023

Journal Articles

Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia: Why Do Adolescents and Young Adults Outcomes Differ from Those of Children? a Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Blood (2021) 138 (Supplement 1): 2921.

https://doi.org/10.1182/blood-2021-146769

Published: 2021

Journal Articles

Stem Cell Transplantation for Diamond-Blackfan Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT)

Blood (2019) 134 (Supplement_1): 44.

https://doi.org/10.1182/blood-2019-124644

Published: 2019

Journal Articles

Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Primary Graft Failure Patients : A Report By the SFGM-TC

Pedro H Prata, MD, Matthieu Resche-Rigon, MD PhD, Didier Blaise, Gérard Socié, MD PhD, Pierre Simon Rohrlich, Noel-Jean Milpied, MD, Pascal Turlure, MD, Stephanie Nguyen, MD PhD, Anne Sirvent, MD, Claude-Eric Bulabois, MD, Eric Deconinck, MD PhD, Amandine Charbonnier, Patrice Chevallier, MD, Jacques-Olivier Bay, MD PhD, Benedicte Neven, MD, Charlotte Jubert, MD, Mohamad Mohty, MD PhD, Marie Thérèse Rubio, MD, Regis Peffault De Latour

Blood (2018) 132 (Supplement 1): 4663.

https://doi.org/10.1182/blood-2018-99-111610

Published: 2018

Journal Articles

Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study

Blood (2018) 132 (7): 750–754.

https://doi.org/10.1182/blood-2018-01-829630

Published: 2018

Includes: Supplemental data

Journal Articles

Efficacy and Safety of Unrelated Cord Blood Transplantation in Patients with Acquired Refractory Aplastic Anemia: A Phase II Study on Behalf of Eurocord and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

Blood (2016) 128 (22): 2671.

https://doi.org/10.1182/blood.V128.22.2671.2671

Published: 2016

Journal Articles

A Composite Event-Free Survival End Point to Evaluate Outcome after Allogeneic Transplantation for Severe Aplastic Anemia: A Study on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Raynier Devillier, MD PhD, Hélène Labussière-Wallet, MD, Laurence Clément, MD, Ibrahim Yakoubagha, Jacques-Olivier Bay, MD PhD, Virginie Gandemer, MD PhD, Marie t Rubio, MD PhD, Anne Sirvent, MD, Patrice Chevallier, MD PhD, Thierry Derevel, Sebastien Maury, MD PhD, Gerard Socie, MD PhD, Regis Peffault de Latour, MD PhD

Blood (2016) 128 (22): 2674.

https://doi.org/10.1182/blood.V128.22.2674.2674

Published: 2016

Journal Articles

Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome

Blood (2016) 127 (26): 3450–3457.

https://doi.org/10.1182/blood-2016-01-694349

Published: 2016

Includes: Supplemental data

Journal Articles

Impact of NK Cell Reconstitution and Recipient HLA-C Typing on Clinical Outcome after Reduced Intensity Cord Blood Transplant: Results of a Prospective Phase II Multicentric Trial on Behalf of Societe Francaise De Greffe De Moelle Osseuse Et Therapie Cellulaire (SFGM-TC) and Eurocord

Blood (2015) 126 (23): 4393.

https://doi.org/10.1182/blood.V126.23.4393.4393

Published: 2015

Journal Articles

Outcome after Relapse or Progression Following First Allogeneic Hematopoietic Stem Cell Transplantation in Children with Acute Leukemia. a Retrospective Analysis from the French Society of Bone Marrow Transplantation and Cell Therapies

Blood (2014) 124 (21): 2510.

https://doi.org/10.1182/blood.V124.21.2510.2510

Published: 2014

Journal Articles

Outcomes after Double Umbilical Cord Blood Transplantation in Children: A Survey on Behalf of Eurocord and PDWP-EBMT

Blood (2014) 124 (21): 2570.

https://doi.org/10.1182/blood.V124.21.2570.2570

Published: 2014

Journal Articles

Similar Outcome Using Sibling, Unrelated Donor, and Cord Blood Grafts after Reduced-Intensity Conditioning in Children: A Retrospective Study from the SFGM-TC

Marion Strullu, Myriam Labopin, Regis Peffaut de Latour, Laurence Clement, Jean-Hugues Dalle, MD PhD, Charlotte Jubert, MD, Gerard Michel, MD, Pierre-Simon Rohrlich, Anne Sirvent, MD, Justyna Kanold, Yves Bertrand, Yves Beguin, MD PhD, Catherine Paillard, Fanny Rialland, MD, Mohamad Mohty, Patrice Chevallier, MD PhD

Blood (2014) 124 (21): 2551.

https://doi.org/10.1182/blood.V124.21.2551.2551

Published: 2014

Journal Articles

Outcomes After a Sequential Clofarabine/Arac-C Chemotherapy Followed By Reduced-Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (allo-SCT) In Pediatrics Patients With JMML Or Primary/Relapsed Refractory AML: A Pilot Study

Grain Audrey, Anne Sirvent, Marion Strullu, Francoise Mechinaud, MD, Mohamad Mohty, MD, PhD, Patrice Chevallier, MD, PhD, Thierry Guillaume, MD, Fanny Rialland, M.D.

Blood (2013) 122 (21): 5460.

https://doi.org/10.1182/blood.V122.21.5460.5460

Published: 2013

Journal Articles

New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation

Blood (2013) 121 (6): 1059–1064.

https://doi.org/10.1182/blood-2012-07-445965

Published: 2013

Includes: Supplemental data

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in First Line High Risk Multiple Myeloma Patients: Evolving Strategies with the Immunomodulating Drugs.

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M., Jean El-Cheikh, MD PhD, Stéphane Morisset, Stat., Anne Sirvent, MD, Oumedaly Reman, MD, Jérôme Cornillon, MD, Reza Tabrizi, MD, Noel Milpied, MD, Jean-Luc Harousseau, MD, Hélène Labussière-Wallet, MD, Franck E. Nicolini, MD, PhD, Charles Dumontet, M. D., Ph.D., Mohamad Mohty, Michel Attal, MD, Didier Blaise, MD, Philippe Moreau, MD, Hervé Avet-Loiseau, MD, PhD

Blood (2012) 120 (21): 3116.

https://doi.org/10.1182/blood.V120.21.3116.3116

Published: 2012

Journal Articles

Unrelated Cord Blood Transplantation Using Myeloablative Conditioning Regimen for Adults with Acute Myeloid Leukemia in First Complete Remission. A Survey by EUROCORD and the Acute Leukemia Working Party of the EBMT

Annalisa Ruggeri, MD, Myriam Labopin, MD, MS, Guillermo Sanz, MD, Josep-Maria Ribera, MD, PhD, Anne Sirvent, MD, Alessandro Rambaldi, Renato Cunha, MD, Fernanda Volt, Eliane Gluckman, MD, PhD, Chantal Kenzey, Mohamad Mohty, William Arcese, MD, Vanderson Rocha, MD, PhD

Blood (2011) 118 (21): 836.

https://doi.org/10.1182/blood.V118.21.836.836

Published: 2011

Journal Articles

Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Myelomonocytic Leukemia (CMML): Prognostic Factors for Survival. A Report From the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC),

Blood (2011) 118 (21): 3794.

https://doi.org/10.1182/blood.V118.21.3794.3794

Published: 2011

NARROW

Chronic Graft-Versus-Host Disease in Long-Term Survivors of Childhood Leukemia

Conditioning Intensity in Patients Aged > 50 Years Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrom: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT

High Body Mass Index Is Associated with Favorable Outcome in Younger Patients Receiving CD19 CAR T-Cell Therapy for B-Cell Lymphoma: A Retrospective Study from the EBMT Transplant Complications Working Party

Interest of Cytoreductive Therapy before Allogenic Hematopoietic Stem Cell Transplantation in Childhood Myelodysplastic Syndromes: A Retrospective Study on Behalf of the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia: Why Do Adolescents and Young Adults Outcomes Differ from Those of Children? a Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Stem Cell Transplantation for Diamond-Blackfan Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT)

Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Primary Graft Failure Patients : A Report By the SFGM-TC

Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study

Efficacy and Safety of Unrelated Cord Blood Transplantation in Patients with Acquired Refractory Aplastic Anemia: A Phase II Study on Behalf of Eurocord and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

A Composite Event-Free Survival End Point to Evaluate Outcome after Allogeneic Transplantation for Severe Aplastic Anemia: A Study on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome

Impact of NK Cell Reconstitution and Recipient HLA-C Typing on Clinical Outcome after Reduced Intensity Cord Blood Transplant: Results of a Prospective Phase II Multicentric Trial on Behalf of Societe Francaise De Greffe De Moelle Osseuse Et Therapie Cellulaire (SFGM-TC) and Eurocord

Outcome after Relapse or Progression Following First Allogeneic Hematopoietic Stem Cell Transplantation in Children with Acute Leukemia. a Retrospective Analysis from the French Society of Bone Marrow Transplantation and Cell Therapies

Outcomes after Double Umbilical Cord Blood Transplantation in Children: A Survey on Behalf of Eurocord and PDWP-EBMT

Similar Outcome Using Sibling, Unrelated Donor, and Cord Blood Grafts after Reduced-Intensity Conditioning in Children: A Retrospective Study from the SFGM-TC

Outcomes After a Sequential Clofarabine/Arac-C Chemotherapy Followed By Reduced-Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (allo-SCT) In Pediatrics Patients With JMML Or Primary/Relapsed Refractory AML: A Pilot Study

New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation in First Line High Risk Multiple Myeloma Patients: Evolving Strategies with the Immunomodulating Drugs.

Unrelated Cord Blood Transplantation Using Myeloablative Conditioning Regimen for Adults with Acute Myeloid Leukemia in First Complete Remission. A Survey by EUROCORD and the Acute Leukemia Working Party of the EBMT

Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Myelomonocytic Leukemia (CMML): Prognostic Factors for Survival. A Report From the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC),

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only